Sorrento Therapeutics Stock Price, News & Analysis
Company Description
Sorrento Therapeutics (OTC Link: SRNE) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $1.9M.
SRNE stock has gained 142.9% over the past year. Shares last traded at $0.0017.
On a trailing twelve-month basis, Sorrento Therapeutics reported revenue of $62.8M with net income of -$572.8M and diluted earnings per share of $-1.37. The company operates at a net profit margin of -911.6%.
This page provides a comprehensive overview of SRNE stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Sorrento Therapeutics (SRNE) stock last traded at $0.0017, up 41.18% from the previous close. Over the past 12 months, the stock has gained 142.9%. At a market capitalization of $1.9M, SRNE is classified as a micro-cap stock with approximately 551.3M shares outstanding.
Latest News
Sorrento Therapeutics has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include dividends, acquisition, fda approval. View all SRNE news →
SEC Filings
Financial Highlights
Sorrento Therapeutics generated $62.8M in revenue over the trailing twelve months, operating income reached -$504.3M (-802.5% operating margin), and net income was -$572.8M, reflecting a -911.6% net profit margin. Diluted earnings per share stood at $-1.37. The company generated -$293.9M in operating cash flow. With a current ratio of 0.29, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Sorrento Therapeutics (SRNE) currently stands at 3.5 million shares, representing 0.6% of the float. This relatively low short interest suggests limited bearish sentiment. With 25.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Sorrento Therapeutics (SRNE) currently stands at 25.0 days, up 96.5% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has decreased 31.1% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 2.1 to 36.2 days.
SRNE Company Profile & Sector Positioning
Sorrento Therapeutics (SRNE) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing SRNE often look at related companies in the same sector, including Aim Immunotech (AIMI), Enzolytics (ENZC), Neon Bloom (NBCO), Algernon Health (AGNPF), and Axim Biotechnologies Inc (AXIM). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SRNE's relative position within its industry.